Earnings History Data for Abbott Laboratories (ABT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Abbott Laboratories

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
17-04-2024 PM ABT Abbott Laboratories 188,940 0.98 0.95 1.03 Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges
[4/17/2024 7:31 AM]
106.15 -3.06 
(-2.80%)
108.58 -0.63 
(-0.58%)
89.67 - 121.64 10,355,100 4,910,000 120,433
24-01-2024 PM ABT Abbott Laboratories 198,240 1.19 1.19 1.03 Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M
[1/24/2024 7:33 AM]
110.69 -3.31 
(-2.90%)
111.00 -3.00 
(-2.63%)
89.67 - 115.83 6,673,578 5,010,000 101,374
18-10-2023 PM ABT Abbott Laboratories 159,970 1.14 1.10 1.15 Abbott Laboratories Non-GAAP EPS of $1.14 beats by $0.04, revenue of $10.14B beats by $320M
[10/18/2023 7:31 AM]
95.69 3.55 
(3.85%)
96.00 3.86 
(4.19%)
89.67 - 115.83 13,778,159 6,020,000 743,144
20-07-2023 PM ABT Abbott Laboratories 186,070 1.08 1.04 1.43 Abbott Laboratories Non-GAAP EPS of $1.08 beats by $0.03, revenue of $10B beats by $280M
[7/20/2023 7:30 AM]
111.74 4.46 
(4.16%)
108.00 0.72 
(0.67%)
93.25 - 115.69 7,274,324 4,810,000 80,517
19-04-2023 PM 7:30 AM ET
(Apr 19)
ABT Abbott Laboratories 180,680 1.03 0.98 1.73 Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.05, revenue of $9.7B beats by $60M
[4/19/2023 7:18 AM]
112.33 8.17 
(7.85%)
108.00 3.85 
(3.70%)
93.25 - 124.35 10,750,010 5,560,000 81,296
25-01-2023 PM 7:30 AM ET
(Jan 25)
ABT Abbott Laboratories 198,780 1.03 0.90 1.32 Abbott Laboratories Non-GAAP EPS of $1.03 beats by $0.10, revenue of $10.1B beats by $410M
[1/25/2023 7:30 AM]
110.74 -1.79 
(-1.59%)
111.00 -1.53 
(-1.36%)
93.25 - 130.93 4,596,412 5,300,000 71,294
19-10-2022 PM 7:30 AM ET
(Oct 19)
ABT Abbott Laboratories 181,290 1.15 0.90 1.40 Abbott Laboratories raises full-year profit guidance, Non-GAAP EPS of $1.15 beats by $0.21, revenue of $10.4B beats by $750M
[10/19/2022 7:33 AM]
98.30 -6.68 
(-6.36%)
101.25 -3.73 
(-3.55%)
96.32 - 142.60 16,086,894 6,070,000 327,191
20-07-2022 PM 7:30 AM ET
(Jul 20)
ABT Abbott Laboratories 190,538 1.43 1.07 0.00 Abbott Laboratories Non-GAAP EPS of $1.43 beats by $0.29, revenue of $11.3B beats by $930M, raises full-year EPS guidance
[7/20/2022 7:32 AM]
108.33 -1.60 
(-1.46%)
106.92 -3.01 
(-2.74%)
101.24 - 142.60 5,507,334 4,600,000 708,391
20-04-2022 PM 7:30 AM ET
(Apr 20)
ABT Abbott Laboratories 205,080 1.73 1.47 1.32 Abbott Laboratories Non-GAAP EPS of $1.73 beats by $0.27, revenue of $11.9B beats by $900M
[4/20/2022 7:31 AM]
122.98 3.01 
(2.50%)
118.40 -1.58 
(-1.32%)
105.36 - 142.60 6,961,756 4,780,000 62,787
26-01-2022 PM 7:30 AM ET
(Jan 26)
ABT Abbott Laboratories 218,950 1.32 1.18 1.45 Abbott Laboratories Non-GAAP EPS of $1.32 beats by $0.11, revenue of $11.5B beats by $790M
[1/26/2022 7:31 AM]
120.24 -3.03 
(-2.46%)
119.52 -3.75 
(-3.04%)
105.36 - 142.60 12,726,601 7,920,000 104,140
20-10-2021 PM 7:15 AM ET
(Oct 20)
ABT Abbott Laboratories 207,100 1.40 0.92 0.98 Abbott Laboratories EPS beats by $0.46, beats on revenue, boost FY guidance
[10/20/2021 7:31 AM]
123.37 4.03 
(3.38%)
124.48 5.14 
(4.31%)
103.13 - 129.70 7,412,725 5,180,000 133,860
22-07-2021 PM 7:30 AM ET
(Jul 22)
ABT Abbott Laboratories 210,960 1.17 1.01 0.57 Abbott Laboratories EPS beats by $0.15, beats on revenue
[7/22/2021 7:16 AM]
118.19 -0.79 
(-0.66%)
117.85 -1.13 
(-0.95%)
98.00 - 128.54 5,421,158 4,610,000 18,457
20-04-2021 PM 7:30 AM ET
(Apr 20)
ABT Abbott Laboratories 220,290 1.32 1.33 0.65 Abbott Laboratories EPS beats by $0.05, misses on revenue
[4/20/2021 7:31 AM]
119.87 -4.66 
(-3.74%)
120.52 -4.01 
(-3.22%)
86.16 - 128.54 8,915,454 4,750,000 126,603
27-01-2021 PM 7:30 AM ET
(Jan 27)
ABT Abbott Laboratories 203,330 1.45 1.36 0.95 Abbott Laboratories EPS beats by $0.10, beats on revenue
[1/27/2021 7:33 AM]
114.40 -0.34 
(-0.29%)
115.52 0.79 
(0.69%)
61.61 - 117.78 7,675,313 4,849,227 58,687
21-10-2020 PM 7:30 AM ET
(Oct 21)
ABT Abbott Laboratories 194,170 0.98 0.90 0.84 Abbott Laboratories EPS beats by $0.07, beats on revenue
[10/21/2020 7:32 AM]
106.13 -2.23 
(-2.06%)
109.90 1.54 
(1.42%)
61.61 - 114.20 4,907,622 4,054,405 89,938
16-07-2020 PM 7:30 AM ET
(Jul 16)
ABT Abbott Laboratories 167,740 0.57 0.43 0.82 Abbott Laboratories EPS beats by $0.15, beats on revenue
[7/16/2020 7:36 AM]
94.92 -1.81 
(-1.87%)
97.70 0.97 
(1.00%)
61.61 - 100.00 3,932,314 4,248,465 103,953